跳至主要内容
临床试验/ACTRN12612000423819
ACTRN12612000423819尚未招募4 期

An evaluation of adverse events and haemodynamic instability resulting from the rapid administration of iron polymaltose infusion in the operating department, in patients with iron deficiency anaemia under general anaesthesia for elective surgical procedures.

Fremantle Hospital0 个研究点目标入组 100 人开始时间: 2012年4月16日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Iron deficiency anaemia defined as Hb < 120g/L if female or Hb < 130g/L if male with ferritin < 100 or Iron deficiency alone, defined as ferritin < 30
  • Elective surgery / procedure requiring general anaesthesia

排除标准

  • Iron overload (haemochromatosis or haemosiderosis) or ferritin > 100
  • Clinically significant renal or liver disease
  • Chronic polyarthritis
  • Active infection
  • Allergy / intolerance to iron polymaltose

研究者

发起方
Fremantle Hospital

相似试验